About Us
We bring together science, technology, and experience for early diagnosis
Colo-Check is an innovative diagnostic solution developed to offer a patient-friendly, molecular-based, and high-performance approach in colorectal cancer screening.
Colo-Check was developed through the combination of experience in medical technology and molecular diagnostics.
Our Vision
Making early diagnosis in colorectal cancer more accessible
Colorectal cancer is one of the cancer types with a high treatment success rate when detected at an early stage. However, concerns about invasive methods may negatively affect participation in screening.
With Colo-Check, our goal is to offer a more comfortable, more applicable screening approach that supports patient compliance by using modern molecular technologies.
Collaboration
Medical device experience and molecular diagnostic expertise
Colo-Check is a strategic collaboration product that brings together Eryiğit Medical Devices’ experience in medical device manufacturing and quality systems with Sentebiolab’s expertise in molecular diagnostics and biotechnology.
With its experience in production, regulation, and quality processes in the field of healthcare technologies and medical devices, it provides a strong industrial infrastructure for the project.
With its scientific expertise in molecular biology, genetic analysis, and epigenetic targeting, it supports Colo-Check’s diagnostic approach.
Scientific accuracy
The test approach targets molecular and epigenetic mechanisms associated with colorectal cancer.
Patient focus
It aims to make the screening experience more acceptable through a non-invasive sampling process.
Quality approach
The aim is to carry out processes in a controlled manner, from sample acceptance to analysis reporting.
Our Mission
Increasing patient compliance in screening processes
In traditional screening methods, preparation, sedation, and the requirement for an invasive procedure may make it difficult for individuals to participate in regular screening. Colo-Check aims to offer a patient-friendly approach that helps reduce these barriers.
Development Focus
Areas where Colo-Check creates value
Our aim is to offer a molecular diagnostic solution that contributes to early diagnosis in colorectal cancer screening, supports patient compliance, and strengthens clinical guidance.
Supports early diagnosis awareness
It offers an accessible screening approach that emphasizes the importance of early diagnosis in colorectal cancer.
Brings molecular data into the clinical process
By targeting epigenetic changes, it helps direct at-risk individuals to further evaluation.
Prioritizes patient-friendly screening
It aims to increase participation in regular screening through a non-invasive sampling approach.
Colo-Check
An innovative collaboration for early diagnosis
With scientific expertise, a quality-driven approach, and patient-focused design, Colo-Check offers a modern support solution in colorectal cancer screening.
